Re: Metformin for Patients with Metastatic Prostate Cancer Starting Androgen Deprivation Therapy: A Randomised Phase 3 Trial of the STAMPEDE Platform Protocol.

Eur Urol

Department of Urology, Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Electronic address:

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2025.08.006DOI Listing

Publication Analysis

Top Keywords

metformin patients
4
patients metastatic
4
metastatic prostate
4
prostate cancer
4
cancer starting
4
starting androgen
4
androgen deprivation
4
deprivation therapy
4
therapy randomised
4
randomised phase
4

Similar Publications

Aims: Despite robust evidence supporting continuous glucose monitoring (CGM) use, successful utilization remains relatively low. This study aimed to determine percentage of patients with a baseline time in range (TIR) <70% who achieved TIR ≥ 70% when using CGM and identify patient variables associated with achievement and/or maintenance of TIR goal within our institution.

Materials And Methods: This was a retrospective, observational review of adult patients with diabetes using CGM for at least 6-months consecutively.

View Article and Find Full Text PDF

Insulin therapy remains a cornerstone in the management of type 2 diabetes mellitus (T2DM), especially in patients experiencing progressive loss of pancreatic beta-cell function or those with inadequate glycemic control despite oral antidiabetic therapy. This review synthesized clinical outcomes from 44 peer-reviewed case reports published between 2019 and 2024, identified through systematic searches in PubMed and Scopus. The included cases involved 15 males and 29 females, with patient ages ranging from 11 to 91 years (mean 53 ± 20.

View Article and Find Full Text PDF

Background: Patients with type 2 diabetes mellitus (T2DM) often experience hypoglycemia, an underappreciated consequence that has a major negative influence on treatment compliance and quality of life.

Objective: This study aimed to determine the prevalence and associated factors of hypoglycemia among patients with T2DM, with a focus on treatment types, comorbidities, and glycemic control. By providing population-specific data, the study intends to inform clinical decision-making and contribute to safer, more personalized diabetes management strategies.

View Article and Find Full Text PDF